The Hindu

CDSCO issues advisory to prevent misleading promotion of prescription drugs for obesity

Activities that exaggerate therapeutic claims, guarantee weight-loss outcomes, or undermine the importance of lifestyle modifications such as diet and physical activity will be treated as misleading promotion